Breast cancer cell-derived EMMPRIN stimulates fibroblast MMP2 release through a phospholipase A2 and 5-lipoxygenase catalyzed pathway
- 13 August 2002
- journal article
- Published by Springer Nature in Oncogene
- Vol. 21 (37) , 5765-5772
- https://doi.org/10.1038/sj.onc.1205702
Abstract
Oncogene is one of the world’s leading cancer journals. It is published weekly and covers all aspects of the structure and function of Oncogenes. Oncogene also publishes 8 Reviews issues a year, on a broad range of topics.Keywords
This publication has 21 references indexed in Scilit:
- Tumorigenic Potential of Extracellular Matrix Metalloproteinase InducerThe American Journal of Pathology, 2001
- Stomach cancer-related mortalityEuropean Journal Of Cancer Prevention, 2001
- Recent Advances in the Treatment of Gastric CancerDrugs, 2001
- Calcium-independent phospholipase A2: structure and functionBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2000
- The TIMP2 Membrane Type 1 Metalloproteinase “Receptor” Regulates the Concentration and Efficient Activation of Progelatinase AJournal of Biological Chemistry, 1998
- Generation of Monoclonal Antibodies to Integrin-associated ProteinsJournal of Biological Chemistry, 1997
- Human Keratinocytes Express EMMPRIN, an Extracellular Matrix Metalloproteinase InducerJournal of Investigative Dermatology, 1996
- Cell surface-mediated activation of progelatinase A: demonstration of the involvement of the C-terminal domain of progelatinase A in cell surface binding and activation of progelatinase A by primary fibroblastsBiochemical Journal, 1994
- Partial sequencing and characterization of the tumor cell-derived collagenase stimulatory factorArchives of Biochemistry and Biophysics, 1991
- A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomasNature, 1990